| Autor: |
Margaryan SR; Pirogov Russian National Research Medical University, Moscow, Russia.; Children's City Clinical Hospital named after N.F. Filatov, Moscow, Russia., Razumovsky AY; Pirogov Russian National Research Medical University, Moscow, Russia.; Children's City Clinical Hospital named after N.F. Filatov, Moscow, Russia., Mitupov ZB; Pirogov Russian National Research Medical University, Moscow, Russia.; Children's City Clinical Hospital named after N.F. Filatov, Moscow, Russia., Gurevich AI; Children's City Clinical Hospital named after N.F. Filatov, Moscow, Russia., Titova EA; Children's City Clinical Hospital named after N.F. Filatov, Moscow, Russia. |
| Abstrakt: |
To date, side-to-side splenorenal shunt (SRS) and its analogues (splenosuprarenal shunts (SSRS)) are mainly used for portal hypertension. These are total portosystemic shunts characterized by total blood shunt from portal vein into inferior vena cava. The latter is fraught with a significant risk of complications such as pulmonary hypertension, decreased portal liver perfusion, liver failure and hepatic encephalopathy. Prevention of these complications is still an urgent problem in modern surgery. However, we proposed a new method of treatment, i.e. reconstruction of SRS and SSRS into selective shunt. This procedure was performed in 37 patients after 2020. We present laparoscopic reconstruction in an 11-year-old girl with portal hypertension and signs of hepatic encephalopathy identified after previous SSRS. |
